Maynard Paton | Page 23 | Quality UK Investment Blog

Getech: 2017 Results Spotlight Product Attractions And Recovery Potential From £9m Market Cap

31 October 2017
By Maynard Paton

Update on Getech (GTC).

Event: Interim results for the twelve months to 31 July 2017 published 31 October 2017

Summary: These results were never going to show a major turnaround, but glimmers of hope continue to emerge at the geoscience software specialist. In particular, a new chief exec has cut costs, reorganised the firm and spotlighted some of the company’s product attractions. True, minimal earnings are likely during the short term. But with the upbeat stock market making obvious buying opportunities hard to find, I am beginning to warm to GTC’s recovery potential. I continue to hold.

System1: H1 Profit Slumps 70% But Finer Details Provide Hope For Shareholders

27 October 2017
By Maynard Paton

Update on System1 (SYS1).

Event: Interim results and shareholder presentation for the six months to 30 September 2017 published 27 October 2017

Summary: The marketing-services group had already alerted investors to these disappointing figures. However, the setback was explained honestly by management and I note 50% of the business continues to grow at a fair rate. So everything does not appear completely lost just yet. That said, adopting the tag of industry ‘pioneer’ will always court competition and it seems rivals have tempted some customers away. The share price has been thumped since the summer, but is now looking quite interesting. I continue to hold.

Tristel: I Had To Delve Deep Into These 2017 Results After Underlying Revenue Gained Only 7%

25 October 2017
By Maynard Paton

Update on Tristel (TSTL).

Event: Final results and shareholder presentation for the year to 30 June 2017 published 19 October 2017

Summary: July’s trading statement from this medical disinfectants specialist had already signalled these record results. However, the update showed underlying revenue growth of just 7%, with the UK up 3% and overseas up 10%. I’ve therefore had to delve deep into the numbers to ensure TSTL’s main products continue to sell relatively well. At least the company’s accounts and recent acquisition showed more obvious appeal. I must confess, I am nervous comparing the share-price valuation against the medium-term expansion potential, especially with the prospect of sizeable North American revenue as distant as ever. I continue to hold.

Bioventix: Outstanding 2017 Results But Cagey Troponin Remarks May Leave 29x P/E Rather Exposed

16 October 2017
By Maynard Paton

Update on Bioventix (BVXP).

Event: Preliminary results for the year to 30 June 2017 published 16 October 2017

Summary: The antibody specialist delivered another outstanding set of results, as astonishing margins, robust cash production and magnificent equity returns once again underlined the group’s wonderful economics. However, matters were tempered somewhat by management remarks about the immediate revenue potential of a new product. It could mean progress during 2018 won’t be very impressive, which may leave the current 29x multiple rather exposed. I’m hoping things work out for the best, and continue to hold.

Q3 2017: 2 Top-Ups And 1 Top-Slice, Plus Management Ratings From A+ To E

29 September 2017
By Maynard Paton

Happy Friday! I hope you continue to enjoy my Blog… and that your shares have fared well during the summer.

After experiencing positive first and second quarters, my portfolio has maintained its gains and its performance has improved to 14.0% for the year so far.

Furthermore, following an inactive second quarter, I have since dusted off my share-dealing account and executed a few buys and sells.

I have top-sliced one holding and added to two existing holdings. More on those trades a bit later.

Sadly, I have to admit that — once again! — a lot of my time of late has been absorbed by matters outside of investing.

While I’ve managed to keep on top of the news from my own portfolio, I’ve still not had the chance to study other companies and publish fresh watch-list reviews.

Andrews Sykes: H1 Profit Up 28% And Now On Course For Best Year Ever

28 September 2017
By Maynard Paton

Update on Andrews Sykes (ASY).

Event: Interim results for the six months to 30 June 2017 published 28 September 2017

Summary: I was very satisfied with ASY’s first-half progress. The specialist hire group reported positive performances both within the UK and overseas and could now be on course to deliver its best-ever annual results. A 20%-plus operating margin and substantial net cash remain key bookkeeping features, while management hints of an encouraging second half have kept the share price buoyant. I continue to hold.

S & U: Heading Towards 18 Years Of Unbroken Growth As Chairman Shrugs Off Rising Bad-Debt Worries

26 September 2017
By Maynard Paton

Update on S & U (SUS)

Event: Interim results for the six months to 31 July 2017 published 26 September 2017.

Summary: These results displayed further “steady and sustainable” growth from the used-car loan firm. Although the seasoned executives remain optimistic about the group’s prospects and the wider economy, margins have dipped once again as the impairment charge representing potential bad loans continues to rise. Still, the 11-12x multiple appears modest given the company’s growth rate and there is a near-5% income, too. I continue to hold.

FW Thorpe: Record Annual Results Spotlight Further Double-Digit Growth As Dividend Lifted For 15th Consecutive Year

22 September 2017
By Maynard Paton

Quick update on FW Thorpe (TFW).

Event: Preliminary results for the twelve months to 30 June 2017 published 21 September 2017

Summary: Yet again this lighting specialist has delivered a very satisfactory annual performance, with revenue and profit attaining fresh all-time highs and the dividend lifted for the fifteenth consecutive year. Although the group’s largest division appears to be performing very well, other subsidiaries did not enjoy the very best of second halves. Management comments about 2018 seemed quite cautious, too. The accounts remain in pristine condition, but I am mindful of the shares trading at a rich multiple. I continue to hold.

M Winkworth: H1 Revenue Drops 7% As Management Continues To Outperform Foxtons And Now Looks Towards Growth

13 September 2017
By Maynard Paton

Quick update on M Winkworth (WINK).

Event: Interim results for the six months to 30 June 2017 published 13 September 2017

Summary: These figures could have been a lot worse, given the estate-agency firm remains dependent mostly on the standstill London property market. The major highlight derived from the statement was that WINK continues to outperform Foxtons, and it appears the group is now using the difficult sector to expand its franchising network. Meanwhile, the financials remain in order, the outlook seems relatively promising and yet the valuation is still in the doldrums. I continue to hold.

Tasty: Grim H1 Results Reveal Huge £9.3m Write-Off, But Recovery Hopes Remain As Management Finally Shows Greater Turnaround Urgency

12 September 2017
By Maynard Paton

Quick update on Tasty (TAST).

Event: Interim results for the 26 weeks to 02 July 2017 published 12 September 2017

Summary: These results were always going to be somewhat grim, and news of a £9.3m write-off suggests about a third of TAST’s restaurant estate has now suffered trading problems during the last 18 months. At least the board is currently showing greater urgency with its turnaround plan and I would like to think these figures mark the low point for the group’s finances. I continue to believe the long-term upside could be considerable if a successful recovery one day prompts further restaurant expansion. I continue to hold.

Mincon: H1 Revenue Up 29% As New Projects Set To Herald Further ‘Meaningful’ Growth

06 September 2017
By Maynard Paton

Quick update on Mincon (MCON).

Event: Interim results for the six months ending 30 June 2017 published 17 August 2017

Summary: A very welcome set of results, which I calculate included the drill specialist’s best-ever quarter as a quoted company. Revenue and profit enjoyed significant advances, and it appears the group’s mining customers are now happy to place greater orders following the sector downturn of the last few years. Also pleasing was the improvement to cash flow and the possibility of certain new projects providing further “meaningful” growth. I continue to hold.

City Of London Investment: Dividend Lifted For First Time Since 2011 As New Bonus Scheme Gets Ready To Pinch 2% Of Revenue

03 August 2017
By Maynard Paton

Quick update on City of London Investment (CLIG).

Event: Trading statement and shareholder presentation for the year ending 30 June 2017 published 19 July 2017

Summary: Earlier updates had already signalled these summary annual results would be positive. However, the fund manager’s progress was supported entirely by favourable markets and currency movements — the year actually witnessed a net outflow of client money. Still, the icing on the cake was the first dividend lift for six years and, despite the share price climbing since this time last year, the payout still supports a 6% income. The presentation also outlined the potential cost of the new staff bonus scheme, and I am hopeful the cited 2% of revenue will not eventually rise towards the scheme’s 5% limit. I continue to hold.

Tristel: Second Open Day Showcases Positive US Promise In The Car-Park Marquee

26 July 2017
By Maynard Paton

Long update on Tristel (TSTL).

Event: Shareholder open-day presentation and trading update for the year ending 30 June 2017 published 19 July 2017

Summary: Similar to last year’s open day, this was a very useful shareholder event that accompanied a better-than-expected trading update. However, I thought the lack of any reference to UK revenue was odd and I await October’s full-year results for the finer details. For now at least, the disinfection specialist appears on course to meet its three-year targets and there are some promising developments with the planned venture into North America. Plenty of optimism, though, appears to be priced into the shares. I continue to hold.

Daejan: Annual Results Defy Management’s Brexit Gloom As NAV Reaches New £102 Per Share High

13 July 2017
By Maynard Paton

Quick update on Daejan (DJAN).

Event: Preliminary results for the year to 31 March 2017 published 12 July 2017

Summary: This time last year DJAN’s management was full of Brexit gloom, but here we are now with the commercial property group declaring new highs for revenue, net asset value and the dividend. Of course, the board’s caution may eventually prove to be shrewd, and I’m hopeful the veteran executives will be able to navigate through any wider property uncertainty — assisted in part by the firm’s relatively low level of debt. The shares trade at 63% of net asset value and I continue to hold.

Q2 2017: No Buys Or Sells, Plus Business ‘Moats’ Versus Motivated Bosses

30 June 2017
By Maynard Paton

Happy Friday! I hope you continue to find my Blog useful… and that your portfolio is still performing well during 2017.

After experiencing a buoyant start to the year, I am pleased my investments have generally held on to their value during the last few months.

All in all, the recent news from my portfolio has not been too bad, with a few minor share-price gains helping my performance improve to 9.5% for the year so far.

Maynard Paton: “Andrews Sykes (ASY) Publication of 2023 annual report (continued) Moving onto a separate comment as the previous comment I think…” 20 Apr 2025

Maynard Paton: “Thanks m! Maynard” 18 Apr 2025

m: “as always, an interesting read. thanks” 18 Apr 2025

Maynard Paton: “Andrews Sykes (ASY) Publication of 2023 annual report Here are the points of interest beyond those noted in the blog…” 17 Apr 2025

Maynard Paton: “Bioventix (BVXP) Plasma levels of the neuron damage markers brain-derived tau and glial fibrillary acidic protein in Lyme neuroborreliosis: A…” 14 Apr 2025

Maynard Paton: “Hi Adrian, well spotted, I did not think anyone would notice! There was some discrepancy between the figures BVXP published.…” 09 Apr 2025

Adrian: “It was £239k of Chinese revenues, not £235k – small point!” 06 Apr 2025

Maynard Paton: “S & U (SUS) FCA Written submission to the Supreme Court – 10 March 2025 published 01 April 2025 A…” 05 Apr 2025